WEDNESDAY, Nov. 30, 2022 (HealthDay News) — The experimental Alzheimer’s drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelling and brain bleeds remain. In the eagerly awaited trial findings, published Tuesday in the New EnglandContinue Reading

TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer’s drug, calling into question the medication’s safety. A 65-year-old woman with early-stage Alzheimer’s recently died from a massive brain bleed that some researchers link to lecanemab, anContinue Reading

FRIDAY, Nov. 18, 2022 (HealthDay News) — A severely paralyzed person no longer needs to go through brain surgery to try and steer a motorized wheelchair with their mind, researchers report. Through an electrode-studded cap placed on their head, several people with quadriplegia — no function in all four limbsContinue Reading

MONDAY, Nov. 14, 2022 (HealthDay News) — The EpiPen is a known lifesaver when someone with a serious food allergy eats something they can’t tolerate. Yet the auto-injection treatment is greatly underused in the United States, according to a new survey. Just over half of at-risk adults said they hadContinue Reading